CaliPharms OverviewCaliPharms EBIT
EBIT (Earnings Before Interest and Taxes) analysis for KGET.
Quarterly EBIT
-$231.56K
↓ 534.24% YoY
As of Sep 30, 2014
Annual EBIT (TTM)
-$822.17K
↓ 662.43% YoY
Trailing 12 months ending Sep 30, 2014
CaliPharms OverviewEBIT (Earnings Before Interest and Taxes) analysis for KGET.
As of Sep 30, 2014
Trailing 12 months ending Sep 30, 2014